Expression of Concern to: Fetal Safety of Dydrogesterone Exposure in the First Trimester of Pregnancy (Clinical Drug Investigation, (2020), 40, 7, (679), 10.1007/s40261-019-00862-w)

Gideon Koren, Daniella Gilboa, Rachel Katz

Research output: Contribution to journalComment/debate

5 Scopus citations

Abstract

The Editor-in-Chief of Clinical Drug Investigation has become aware that the original article contains a number of errors and inconsistencies.

Original languageEnglish
Pages (from-to)681
Number of pages1
JournalClinical Drug Investigation
Volume40
Issue number7
DOIs
StatePublished - 1 Jul 2020

Fingerprint

Dive into the research topics of 'Expression of Concern to: Fetal Safety of Dydrogesterone Exposure in the First Trimester of Pregnancy (Clinical Drug Investigation, (2020), 40, 7, (679), 10.1007/s40261-019-00862-w)'. Together they form a unique fingerprint.

Cite this